94 related articles for article (PubMed ID: 24508768)
21. Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.
Gowd KH; Han TS; Twede V; Gajewiak J; Smith MD; Watkins M; Platt RJ; Toledo G; White HS; Olivera BM; Bulaj G
Biochemistry; 2012 Jun; 51(23):4685-92. PubMed ID: 22594498
[TBL] [Abstract][Full Text] [Related]
22. Characterization of conantokin Rl-A: molecular phylogeny as structure/function study.
Gowd KH; Watkins M; Twede VD; Bulaj GW; Olivera BM
J Pept Sci; 2010 Aug; 16(8):375-82. PubMed ID: 20572027
[TBL] [Abstract][Full Text] [Related]
23. μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve.
Wilson MJ; Yoshikami D; Azam L; Gajewiak J; Olivera BM; Bulaj G; Zhang MM
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10302-7. PubMed ID: 21652775
[TBL] [Abstract][Full Text] [Related]
24. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors.
Sheng Z; Prorok M; Castellino FJ
Neuroscience; 2010 Oct; 170(3):703-10. PubMed ID: 20688135
[TBL] [Abstract][Full Text] [Related]
25. Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
Mosley CA; Acker TM; Hansen KB; Mullasseril P; Andersen KT; Le P; Vellano KM; Bräuner-Osborne H; Liotta DC; Traynelis SF
J Med Chem; 2010 Aug; 53(15):5476-90. PubMed ID: 20684595
[TBL] [Abstract][Full Text] [Related]
26. N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse.
Costa BM; Feng B; Tsintsadze TS; Morley RM; Irvine MW; Tsintsadze V; Lozovaya NA; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2009 Nov; 331(2):618-26. PubMed ID: 19684252
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors.
Mosley CA; Myers SJ; Murray EE; Santangelo R; Tahirovic YA; Kurtkaya N; Mullasseril P; Yuan H; Lyuboslavsky P; Le P; Wilson LJ; Yepes M; Dingledine R; Traynelis SF; Liotta DC
Bioorg Med Chem; 2009 Sep; 17(17):6463-80. PubMed ID: 19648014
[TBL] [Abstract][Full Text] [Related]
28. The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
Sheng Z; Liang Z; Geiger JH; Prorok M; Castellino FJ
Neuropharmacology; 2009 Aug; 57(2):127-36. PubMed ID: 19427876
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.
Twede VD; Miljanich G; Olivera BM; Bulaj G
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):231-9. PubMed ID: 19333868
[TBL] [Abstract][Full Text] [Related]
30. Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor.
Twede VD; Teichert RW; Walker CS; Gruszczyński P; Kaźmierkiewicz R; Bulaj G; Olivera BM
Biochemistry; 2009 May; 48(19):4063-73. PubMed ID: 19309162
[TBL] [Abstract][Full Text] [Related]
31. Integrating the discovery pipeline for novel compounds targeting ion channels.
Bulaj G
Curr Opin Chem Biol; 2008 Aug; 12(4):441-7. PubMed ID: 18678277
[TBL] [Abstract][Full Text] [Related]
32. Anatomical localization and expression pattern for the NMDA-2D receptor subunit in a rat model of neuropathic pain.
Hummel M; Strassle B; Miller S; Kaftan E; Whiteside G
Neuroscience; 2008 Aug; 155(2):492-502. PubMed ID: 18585442
[TBL] [Abstract][Full Text] [Related]
33. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.
Khosravani H; Zhang Y; Tsutsui S; Hameed S; Altier C; Hamid J; Chen L; Villemaire M; Ali Z; Jirik FR; Zamponi GW
J Cell Biol; 2008 May; 181(3):551-65. PubMed ID: 18443219
[TBL] [Abstract][Full Text] [Related]
34. Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors.
Teichert RW; Jimenez EC; Twede V; Watkins M; Hollmann M; Bulaj G; Olivera BM
J Biol Chem; 2007 Dec; 282(51):36905-13. PubMed ID: 17962189
[TBL] [Abstract][Full Text] [Related]
35. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly.
Schüler T; Mesic I; Madry C; Bartholomäus I; Laube B
J Biol Chem; 2008 Jan; 283(1):37-46. PubMed ID: 17959602
[TBL] [Abstract][Full Text] [Related]
36. Diversity of the neurotoxic Conus peptides: a model for concerted pharmacological discovery.
Olivera BM; Teichert RW
Mol Interv; 2007 Oct; 7(5):251-60. PubMed ID: 17932414
[TBL] [Abstract][Full Text] [Related]
37. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides.
Sheng Z; Dai Q; Prorok M; Castellino FJ
Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620
[TBL] [Abstract][Full Text] [Related]
38. Conus peptides: biodiversity-based discovery and exogenomics.
Olivera BM
J Biol Chem; 2006 Oct; 281(42):31173-7. PubMed ID: 16905531
[No Abstract] [Full Text] [Related]
39. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia.
Micu I; Jiang Q; Coderre E; Ridsdale A; Zhang L; Woulfe J; Yin X; Trapp BD; McRory JE; Rehak R; Zamponi GW; Wang W; Stys PK
Nature; 2006 Feb; 439(7079):988-92. PubMed ID: 16372019
[TBL] [Abstract][Full Text] [Related]
40. The Amber biomolecular simulation programs.
Case DA; Cheatham TE; Darden T; Gohlke H; Luo R; Merz KM; Onufriev A; Simmerling C; Wang B; Woods RJ
J Comput Chem; 2005 Dec; 26(16):1668-88. PubMed ID: 16200636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
